ScreenerHero

AUNA Auna SA

NYSE · US · Healthcare · Medical Care Facilities · aunainvestors.com
5.050USD-1.37%Mkt Cap: 373.98M $P/E: 84.17

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare; dental and vision insurance; and oncology plans. It also sells medicines. A…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$97.43BUSDP/E 14.7
FRE
Fresenius SE & Co. KGaA
$26.50BUSDP/E 15.6
THC
Tenet Healthcare Corporation
$20.92BUSDP/E 10.1
EHC
Encompass Health Corporation
$12.08BUSDP/E 20.5
DVA
DaVita Inc.
$11.35BUSDP/E 14.9
FME
Fresenius Medical Care AG
$10.92BUSDP/E 11.3
FMS
Fresenius Medical Care AG
$11.01BUSDP/E 10.7
UHS
Universal Health Services, Inc.
$10.29BUSDP/E 7.1
ENSG
The Ensign Group, Inc.
$9.86BUSDP/E 26.5
PACS
PACS Group, Inc.
$6.84BUSDP/E 25.3
CHE
Chemed Corporation
$6.55BUSDP/E 25.2
OPCH
Option Care Health, Inc.
$4.65BUSDP/E 23.5
CON
Concentra Group Holdings Parent, Inc.
$4.64BUSDP/E 23.5
LFST
LifeStance Health Group, Inc.
$4.60BUSDP/E 93.2
MCOV-B
Medicover AB (publ)
$3.78BUSDP/E 42.6
NHC
National HealthCare Corporation
$3.46BUSDP/E 24.9
ACHC
Acadia Healthcare Company, Inc.
$2.72BUSD
AVAH
Aveanna Healthcare Holdings Inc.
$2.69BUSDP/E 9.8
GRDN
Guardian Pharmacy Services, Inc.
$2.58BUSDP/E 39.5
BKD
Brookdale Senior Living Inc.
$2.57BUSD
HeadlineSourceTime
Older
Auna SA (AUNA) (Q2 2026) Earnings Call Highlights: Revenue Climbs 9% on Volume Growth, but ...

Strong top-line momentum and robust free cash flow offset temporary margin headwinds in Mexico and Colombia, with full-year guidance reaffirmed.

GuruFocus.com
Auna Q2 Earnings Call Highlights

Auna (NYSE:AUNA) reported second-quarter results marked by continued revenue growth, improving cash generation and a sequential recovery in patient volumes in Mexico, though adjusted EBITDA declined amid margin pressures, talent investments and billing-related penalties in Peru. Executive Chairman

MarketBeat
Auna S.A. Q2 2026 Earnings Call Summary

Moby summary of Auna S.A.'s Q2 2026 earnings call

Moby
Auna S.A. (AUNA) Q2 Earnings Miss Estimates

Auna S.A. (AUNA) delivered earnings and revenue surprises of -42.31% and +2.16%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Cerenome (CNSY) Reports Q2 Loss, Misses Revenue Estimates

Cerenome (CNSY) delivered earnings and revenue surprises of -36.46% and -60.86%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Fate Therapeutics (FATE) Reports Q2 Loss, Tops Revenue Estimates

Fate Therapeutics (FATE) delivered earnings and revenue surprises of +10.71% and +108.20%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Auna S.A. (AUNA) Expected to Beat Earnings Estimates: Should You Buy?

Auna S.A. (AUNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates

Surgery Partners (SGRY) delivered earnings and revenue surprises of +400.00% and +1.62%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates

Progyny (PGNY) delivered earnings and revenue surprises of +7.84% and +0.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Solventum (SOLV) Q2 Earnings and Revenues Top Estimates

Solventum (SOLV) delivered earnings and revenue surprises of +33.51% and +2.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks